
Wednesday, June 19, 2024 12:56:12 PM
Recent MDWK News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2025 02:47:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 07:17:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 07:17:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2025 09:23:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 09:16:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/04/2025 09:15:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/28/2025 12:47:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/28/2025 12:45:20 PM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 03/27/2025 08:56:56 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/25/2025 08:10:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2025 09:28:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2025 09:37:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2025 09:05:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2024 09:00:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2024 02:30:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2024 02:30:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2024 02:00:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/19/2024 02:30:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2024 10:09:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2024 10:08:13 PM
FEATURED Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM
VAYK Discloses More Insider Buying Approaching 15 Million • VAYK • Jul 2, 2025 10:37 AM